These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 35985830

  • 1. Six-Minute Walk as a Measure of Walking Capacity and Endurance in Patients With Pediatric-Onset Multiple Sclerosis.
    Brenton JN, Florenzo B, Koshiya H, Min S, Woolbright E, Coleman R, Chen S, Goldman M.
    Neurology; 2022 Nov 07; 99(19):e2161-e2170. PubMed ID: 35985830
    [Abstract] [Full Text] [Related]

  • 2. Symptomatic correlates of six-minute walk performance in persons with multiple sclerosis.
    Motl RW, Balantrapu S, Pilutti L, Dlugonski D, Suh Y, Sandroff BM, Lane A, Fernhall B.
    Eur J Phys Rehabil Med; 2013 Feb 07; 49(1):59-66. PubMed ID: 22820825
    [Abstract] [Full Text] [Related]

  • 3. Walking endurance in multiple sclerosis: Meta-analysis of six-minute walk test performance.
    Cederberg KLJ, Sikes EM, Bartolucci AA, Motl RW.
    Gait Posture; 2019 Sep 07; 73():147-153. PubMed ID: 31326830
    [Abstract] [Full Text] [Related]

  • 4. Sleep, physical activity, and psychological outcomes in children and adolescents with pediatric onset multiple sclerosis.
    Stephens S, Motl RW, Narang I, Weiss S, Finlayson M, Yeh EA.
    Mult Scler Relat Disord; 2023 Nov 07; 79():105025. PubMed ID: 37776826
    [Abstract] [Full Text] [Related]

  • 5. Quantifying six-minute walk induced gait deterioration with inertial sensors in multiple sclerosis subjects.
    Engelhard MM, Dandu SR, Patek SD, Lach JC, Goldman MD.
    Gait Posture; 2016 Sep 07; 49():340-345. PubMed ID: 27479220
    [Abstract] [Full Text] [Related]

  • 6. Effects of Dalfampridine Extended-release Tablets on 6-minute Walk Distance in Patients With Multiple Sclerosis: A Post Hoc Analysis of a Double-blind, Placebo-controlled Trial.
    Applebee A, Goodman AD, Mayadev AS, Bethoux F, Goldman MD, Klingler M, Blight AR, Carrazana EJ.
    Clin Ther; 2015 Dec 01; 37(12):2780-7. PubMed ID: 26565077
    [Abstract] [Full Text] [Related]

  • 7. Does the six-minute walk test measure walking performance or physical fitness in persons with multiple sclerosis?
    Sandroff BM, Pilutti LA, Motl RW.
    NeuroRehabilitation; 2015 Dec 01; 37(1):149-55. PubMed ID: 26409700
    [Abstract] [Full Text] [Related]

  • 8. Gait Speed Trajectory During the Six-Minute Walk Test in Multiple Sclerosis: A Measure of Walking Endurance.
    Chen S, Sierra S, Shin Y, Goldman MD.
    Front Neurol; 2021 Dec 01; 12():698599. PubMed ID: 34381416
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls.
    Goldman MD, Marrie RA, Cohen JA.
    Mult Scler; 2008 Apr 01; 14(3):383-90. PubMed ID: 17942508
    [Abstract] [Full Text] [Related]

  • 10. Physical activity and walking performance across the lifespan among adults with multiple sclerosis.
    Baird JF, Cederberg KLJ, Sikes EM, Silveira SL, Jeng B, Sasaki JE, Sandroff BM, Motl RW.
    Mult Scler Relat Disord; 2019 Oct 01; 35():36-41. PubMed ID: 31302502
    [Abstract] [Full Text] [Related]

  • 11. Free-Living Peak Cadence in Multiple Sclerosis: A New Measure of Real-World Walking?
    Zheng P, Jeng B, Huynh TLT, Aguiar EJ, Motl RW.
    Neurorehabil Neural Repair; 2023 Oct 01; 37(10):716-726. PubMed ID: 37864454
    [Abstract] [Full Text] [Related]

  • 12. An exploration of impaired walking dynamics and fatigue in multiple sclerosis.
    Burschka JM, Keune PM, Menge U, Hofstadt-van Oy U, Oschmann P, Hoos O.
    BMC Neurol; 2012 Dec 27; 12():161. PubMed ID: 23270547
    [Abstract] [Full Text] [Related]

  • 13. Assessing Walking Ability in People with HTLV-1-Associated Myelopathy Using the 10 Meter Timed Walk and the 6 Minute Walk Test.
    Adonis A, Taylor GP.
    PLoS One; 2016 Dec 27; 11(6):e0157132. PubMed ID: 27336911
    [Abstract] [Full Text] [Related]

  • 14. Real-world walking in multiple sclerosis: Separating capacity from behavior.
    Engelhard MM, Patek SD, Lach JC, Goldman MD.
    Gait Posture; 2018 Jan 27; 59():211-216. PubMed ID: 29078135
    [Abstract] [Full Text] [Related]

  • 15. Physical activity and peak oxygen consumption are associated with walking in multiple sclerosis.
    Hibner BA, Hilgenkamp TIM, Schroeder EC, Motl RW, Bollaert RE, Griffith G, Grigoriadis G, Baynard T, Fernhall B.
    Mult Scler Relat Disord; 2020 May 27; 40():101941. PubMed ID: 31954226
    [Abstract] [Full Text] [Related]

  • 16. Comparison of patient-reported outcomes of physical activity and accelerometry in people with multiple sclerosis and ambulatory impairment: A cross-sectional study.
    Wanitschek A, Seebacher B, Muehlbacher A, Brenneis C, Ehling R.
    Mult Scler Relat Disord; 2024 May 27; 85():105532. PubMed ID: 38452648
    [Abstract] [Full Text] [Related]

  • 17. No association between body composition and walking outcomes in multiple sclerosis.
    Jeng B, Motl RW.
    Mult Scler Relat Disord; 2022 Dec 27; 68():104242. PubMed ID: 36274282
    [Abstract] [Full Text] [Related]

  • 18. Accelerometry is associated with walking mobility, not physical activity, in persons with multiple sclerosis.
    Weikert M, Suh Y, Lane A, Sandroff B, Dlugonski D, Fernhall B, Motl RW.
    Med Eng Phys; 2012 Jun 27; 34(5):590-7. PubMed ID: 21968005
    [Abstract] [Full Text] [Related]

  • 19. Accelerometer-determined physical activity and walking capacity in persons with Down syndrome, Williams syndrome and Prader-Willi syndrome.
    Nordstrøm M, Hansen BH, Paus B, Kolset SO.
    Res Dev Disabil; 2013 Dec 27; 34(12):4395-403. PubMed ID: 24139709
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.